Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 17.85 USD -1.6%
Market Cap: 195.3m USD
Have any thoughts about
Medifast Inc?
Write Note

Medifast Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medifast Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medifast Inc
NYSE:MED
Cost of Revenue
-$176.7m
CAGR 3-Years
21%
CAGR 5-Years
-1%
CAGR 10-Years
-9%
Estee Lauder Companies Inc
NYSE:EL
Cost of Revenue
-$4.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Bellring Brands Inc
NYSE:BRBR
Cost of Revenue
-$1.3B
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Coty Inc
NYSE:COTY
Cost of Revenue
-$2.2B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
-2%
Inter Parfums Inc
NASDAQ:IPAR
Cost of Revenue
-$627.3m
CAGR 3-Years
-18%
CAGR 5-Years
-15%
CAGR 10-Years
-10%
elf Beauty Inc
NYSE:ELF
Cost of Revenue
-$353.1m
CAGR 3-Years
-38%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
No Stocks Found

Medifast Inc
Glance View

Market Cap
195.2m USD
Industry
Consumer products

Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

MED Intrinsic Value
20.53 USD
Undervaluation 13%
Intrinsic Value
Price

See Also

What is Medifast Inc's Cost of Revenue?
Cost of Revenue
-176.7m USD

Based on the financial report for Sep 30, 2024, Medifast Inc's Cost of Revenue amounts to -176.7m USD.

What is Medifast Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-9%

Over the last year, the Cost of Revenue growth was 50%. The average annual Cost of Revenue growth rates for Medifast Inc have been 21% over the past three years , -1% over the past five years , and -9% over the past ten years .

Back to Top